Avigen raises €345K Seed round
31 March 2025· London, United Kingdom· health, biotech, robotics, b2b, software_hardware
The investment will enable the company to sustain its research and development programmes, expand its team, and scale operations in preparation for the commercial rollout of its immunotherapy CRO services.
Investors
LeadSFC Capital
Also participating
British Business BankICUReImperial White City Incubator
About Avigen
Key People
Tobias GamperCo-Founder & CEO
Neelima KcCo-Founder & COO
Sam AuCo-Founder & Scientific Advisor
Stage
Seed
Headquarters
London, United Kingdom
Founded
2025
Team Size
6–20
Sectors
healthbiotechroboticsb2bsoftware_hardware
Source: https://avigen.bio